top of page
In the States.jpg

IN THE STATES

The biopharmaceutical sector has a positive impact in the U.S. by providing jobs, economic output & clinical trial data. Beyond these traditional indicators, however, its full economic footprint can be measured in part by its impact on the vendors, large and small, that provide services or supplies to America’s biopharmaceutical research companies.

To provide insight into the breadth and depth of the industry’s direct impact, We Work For Health gathered data that illustrates jobs, economic impact and clinical trial data for the industry as a whole, and 2022 vendor/supplier data from 15 major biopharmaceutical companies in 50 states, the District of Columbia and Puerto Rico.

Direct Jobs Supported by the Industry

1,049,839

Total Jobs Supported by the Industry

4,926,497

Total Vendor Spending

$71.6B+

Total Clinical Trials

88,961

Click on each state for detailed info illustrating jobs & economic impact data, clinical trial data, and vendor/supplier data:

We Work For Health brings together national and local business leaders, labor, biopharma, patient advocacy, and other healthcare-related stakeholders to support policies and initiatives that foster innovation and facilitate the delivery of lifesaving and life-enhancing medicines. 

We Work For Health. © 2023 All Rights Reserved.

bottom of page